close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about EXEL

Recent news which mentions EXEL

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
Tickers ABBV ACER ARDX CLDX
Tags NVCR IONS biotech catalysts
From Benzinga
The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK
Tickers ACIU ACLX ACOR AQST
Tags Small Cap Penny Stocks RHHBY
From Benzinga
Exelixis-BioInvent Establish Immuno-Oncology Pact
Tickers BOVNF EXEL
Tags Penny Stocks EXEL BOVNF
From Benzinga
4 Supercharged Growth Stocks Billionaires Can't Stop Buying
Tickers EXEL SKLZ SQ TSLA
Tags TSLA Market News SKLZ
From Motley Fool
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on
Tickers ADT ALB AVLR BILL
Tags ADT ROKU ZM
From InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Tickers ACRX CYAD DAWN DRTS
Tags ACRX CYAD DAWN
From Benzinga
Can This Cancer Stock Maintain Its Momentum?
Tickers EXEL
Tags EXEL Recent Press Releases Market News
From Motley Fool
Buying These 3 Stocks Could Be the Smartest Investing Move You Ever Make
Tickers BMY ETSY EXEL IPSEY
Tags BMY IPSEY Market News
From Motley Fool
Exelixis (EXEL) Q1 2022 Earnings Call Transcript
Tickers EXEL
Tags Market News Recent Press Releases EXEL
From Motley Fool
Exelixis: Q1 Earnings Insights
Tickers EXEL
Tags EXEL Market News Earnings
From Benzinga
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
Tickers AGEN ARWR ATNX AVGR
Tags Offerings Financing ARWR
From Benzinga
3 Growth Stocks to Buy With $1,000 Right Now
Tickers BMY CURLF EXEL PINS
Tags EXEL Recent Press Releases PINS
From Motley Fool
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
Tickers ACAD AQST BIIB BLTE
Tags OCUL Health Care Offerings
From Benzinga
Ipsen - Exelixis' Cabometyx Scores European Approval As Second-Line Treatment For Thyroid Cancer
Tickers EXEL IPSEF IPSEY
Tags IPSEY News Health Care
From Benzinga
7 Top-Rated Biotech Stocks to Buy for Q2
Tickers BCRX BNTX EXEL ITOS
Tags BNTX Stocks to Buy PFE
From InvestorPlace
Nasdaq Bear Market: 3 of the Safest Stocks to Buy on the Dip
Tickers AVGO BRK-A BRK-B EXEL
Tags Market News Recent Press Releases EXEL
From Motley Fool
3 No-Brainer Stocks to Buy With $1,000 During the Market Sell-Off
Tickers AVGO EXEL FB
Tags Market News FB AVGO
From Motley Fool
2 Stocks Defying the Market Sell-Off Right Now
Tickers BMY EXEL
Tags Recent Press Releases EXEL Market News
From Motley Fool
EMA's Scientific Committee Backs Expanded Use Of Exelixis, Ipsen's Cabometyx In Thyroid Cancer
Tickers EXEL IPSEF IPSEY
Tags Health Care IPSEF EXEL
From Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
Tickers ALT ANAB ANIP ATHX
Tags IDYA GMDA ANIP
From Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
Tickers BAYRY BAYZF EXEL IPSEY
Tags General Biotech BAYZF
From Benzinga
3 Stocks That Can Turn $10,000 Into $50,000 by 2025
Tickers EXEL FIGS NVAX
Tags Market News FIGS NVAX
From Motley Fool
2 Biotech Stocks That Could Make You Richer
Tickers BMY EXEL ICPT RHHBY
Tags BMY ICPT Market News
From Motley Fool
3 Surefire Stocks to Buy Hand Over Fist During the Stock Market Sell-Off
Tickers EXEL GM MA
Tags Recent Press Releases GM EXEL
From Motley Fool
Exelixis (EXEL) Q4 2021 Earnings Call Transcript
Tickers EXEL
Tags EXEL Recent Press Releases Market News
From Motley Fool
Exelixis: Q4 Earnings Insights
Tickers EXEL
Tags Benzinga BZI/Recaps Market News
From Benzinga
Earnings Scheduled For February 17, 2022
Tickers AAWW AEE AEL AL
Tags VTR LTHM CHUY
From Benzinga
Earnings Preview For Exelixis
Tickers EXEL
Tags Earnings Market News Benzinga
From Benzinga
Bristol Myers, Exelixis Tout Additional Opdivo/Cabometyx Combo Data From Kidney Cancer Trial
Tickers BMY EXEL
Tags Health Care News Phase 3 Trial
From Benzinga
2 Biotech Stocks That Could Make You Richer
Tickers BLUE EXEL TSVT
Tags Market News Recent Press Releases BLUE
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today